I think part of the problem right now is lack of consistent daily volume. Further news might change that and with more volume should come more market interest. That can have a positive feedback on itself.
Canacord's research note target released earlier this month of $5.60 is an attractive near term target offering 64% gains from here.
Ann: $250K Convertible Note Drawdown to Fund Expansion, page-87
Add SPA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.004(16.7%) |
Mkt cap ! $9.42M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 2.0¢ | $955 | 47.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 292290 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
2.1¢ |
Change
-0.004 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.0¢ | 2.1¢ | 2.0¢ | 104770 | ||
| Last updated 13.40pm 26/04/2024 ? | |||||
| SPA (ASX) Chart |